On October 17, 2018, Canada became the first G7 country to legalize cannabis on a national level. Since that time, unprecedented levels of capital, investment, research, and innovation have shaped Canada’s cannabis market into a global leader.
In order to maintain that first-mover advantage, smart, strategic public policy will continue to play a pivotal role in the years to come.
Join Canada 2020 on the anniversary of legalization for Canadian Grown, The 2020 Cannabis Public Policy Conference, hosted in partnership with Genome Canada, for an in-depth look at the policy, science and business forces shaping Canada’s cannabis industry.
Election 43 & Cannabis Policy
Agenda setting for the incoming administration, and mapping Year 2 scenarios for Bill C-45.
Industrial Policy & Market Structure
Firmly establishing cannabis as a top-tier industrial sector within government and analyzing the ways public policy and market forces intersect and enable growth.
Science, Research & Genomics
Forging a path to cannabis’ untapped genomic potential, and targeting the policy frameworks that will enable new research, innovation and scientific discovery in Canada.
Global Pressures & Opportunities
Assessing global pressures and determining the international opportunities that can help fuel policy and market momentum.
Hon. Anne McLellan, Senior Partner, Bennett Jones and Co-Chair, Canada’s Task Force on Cannabis Legalization and Regulation
Dr. Mark Ware, Chief Science Officer, Canopy Growth Corporation & Co-Chair, Canada’s Task Force on Cannabis Legalization and Regulation
Alison Gordon, CEO, 48North
Chuck Rifici, Founder, Auxly Group, Nesta, Canopy Growth + others
Marc LePage, President & CEO, Genome Canada
Trevor Fencott, CEO, Fire & Flower Corporation
Trina Fraser, Partner, Brazeau Seller LLP
+ More names announced weekly
Inquiries to email@example.com